Margarida G.
- Country
- Portugal
- Department
- Dermatology
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Long-Term Safety and Efficacy Evaluation of Litifilimab (BIIB059) in Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus
- Efficacy and Safety Evaluation of Litifilimab in Active Subacute and Chronic Cutaneous Lupus Erythematosus Refractory to Antimalarial Therapy
Data & Insights
Has run more than one trial at 188 of 423 partner sites.
Specializations
Dermatological Research
Specializing in the investigation of cutaneous lupus erythematosus (CLE), with particular emphasis on chronic and subacute manifestations of the condition.
- Skin Manifestations Assessment
- Autoimmune Dermatology
- Advanced Therapeutic Approaches
Primary focus on evaluating novel therapeutic interventions for managing skin-related symptoms in autoimmune conditions.
Immunology Studies
Dedicated to exploring innovative immunomodulatory treatments for autoimmune skin disorders, with specific attention to targeted biological therapies.
- Immune System Modulation
- Biological Treatment Assessment
- Long-term Disease Management
Investigates the effectiveness of immune-targeting treatments in managing chronic cutaneous conditions.
Clinical Therapeutics
Focused on advancing treatment options for chronic autoimmune skin conditions, evaluating both efficacy and safety profiles of emerging therapies.
- Treatment Safety Analysis
- Therapeutic Efficacy Assessment
- Patient Response Monitoring
Explores comparative therapeutic approaches in dermatological autoimmune conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.